Helius exceeds stroke study enrollment goals
NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $2.8 ...
PoNS therapy shows promise for MS gait deficits
NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $3.84 ...
bovnews9d
A Major Breakthrough on the Horizon for Helius Medical (HSDT): What’s Next?
Helius Medical’s YTD stock performance is +4.89%, a figure that outpaces the S&P 500’s YTD performance of +1.52%. This points to a promising period for Helius, showing that despite the overall ...
Nasdaq9d
Helius Medical Exceeds Enrollment Target For Stroke Pivotal Study
The stroke registrational program is designed to evaluate the safety and effectiveness of PoNS or Portable Neuromodulation Stimulator in improving balance and gait deficits in chronic stroke ...